Concerto HealthAI announced a deal
with Pfizer, through which Pfizer will
harness Concerto HealthAI’s eurekaHealth AI platform
and real-world data (RWD) to help identify new and more precise treatment
options as well as accelerate completion times for various outcomes studies. Concerto
HealthAI is comprised of the leading healthcare data scientists, health
economists, epidemiologists, and AI software engineers to advance flexible and
increasingly enterprise grade solutions for advancing RWE into
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis has raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The funding comes months after Deep Lens emerged from stealth in October 2018 with a $3.2M seed round, which brings their funding to date total to $17.5
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
Study: Telerehabilitation Could Improve Patients With Late-Stage Cancer
Telerehabilitation services to patients with late-stage cancer can improve their physical function, pain and quality of life while allowing them to spend less time in hospitals and nursing homes, according to recent research led by Andrea Cheville, M.D., a Mayo Clinic physical medicine and rehabilitation physician. The research team also included Timothy Moynihan, M.D.; and Charles Loprinzi, M.D. -- all from Mayo Clinic -- as well as Jeph Herrin, Ph.D., Yale School of Medicine, and Kurt Kroenke,
Read More
Why Walmart Centers of Excellence Model Could Redefine How Employers Deliver Quality Care
Mitigating the cost of healthcare expenses has long been an uphill battle for employers, though the problem has become particularly pressing in recent years. The price tags for routine treatments and specialty services alike are on the rise; patients and payers alike shoulder heavy cost burdens for everyday care needs. The benefits packages that may have provided sufficient coverage a decade ago are now stretching to cover costs -- and the companies paying out those benefits are desperately
Read More
Proteus Launches Digital Cancer Chemotherapy Pill Program for Cancer Patients
Proteus Digital Health, Inc., Fairview Health Services, and the University of Minnesota Health announced that for the first time cancer patients are using digital oncology medicines to support treatment regimens and improve outcomes. This advancement helps patients complete oral chemotherapy cycles while oncologists gain new insights into their patients’ treatment progress and overall health status. Proteus, Fairview, and the University of Minnesota Health unveiled the care model for digital
Read More
Oncology Analytics Raises $21M to Provide Health Plans With Evidence-Based Analytics for Utilization Management
Oncology Analytics, an Atlanta-based digital health startup that provides health plans, providers and patients with an evidence-based, analytics focused approach to utilization management for oncology, today announced it has raised $21 million in Series B funding. The Series B round was led by Oak HC/FT and was joined by new investor McKesson Ventures along with returning investors Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund. The startup plans to use the capital to expand
Read More
Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
Fitango Health Unveils Oncology Precision Medicine App for Providers to Achieve Value-Based Goals
Fitango Health, a provider of integrated care management and patient engagement software, is announcing a transformative new solution, called Fitango Oncology. Fitango Health's innovative application allows healthcare providers to achieve value-based goals through end-to-end engagement spanning the continuum of care.This end-to-end solution is the first of its kind for both oncology and chronic care to integrate decision-support, treatment communication, along with enabling and engaging both
Read More
Integra Connect Launches Advanced Analytics Suite for Oncology Practices
Integra Connect launches advanced analytics suite to help oncology practices improve cost-efficiency and quality of value-based cancer careOncology is the leading driver of cost in the healthcare industry today, increasing 88% (a rise of $20.7 billion) in the last five years. It is for this reason that oncologists need to be able to pull and analyze disparate clinical and financial data in a united format in order to predict high-impact interventions at patient and population levels to curb
Read More
